Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now full pipeline small index

Left Ventricular Systolic Dysfunction: full-pipeline trial registry

3 of 3 indexed Left Ventricular Systolic Dysfunction trials are currently recruiting.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 3 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Left Ventricular Systolic Dysfunction: 3 US clinical trials tracked, 3 recruiting.

Left Ventricular Systolic Dysfunction is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Bayer, running 1 of these trials.

Enrollment posture brief

Registry condition left-ventricular-systolic-dysfunction

OPEN 3 | RECR 100% | LATE 1 | EARLY 1 | RANK #5209 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Left Ventricular Systoli (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Left Ventricular Systolic Dysfunction

Left Ventricular Systolic Dysfunction lists 3 open slots (100% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Left Ventricular Systolic Dysfunction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Left Ventricular Systolic Dysfunction is recruiting above its size-band peers.

    3 of 3 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21Phase 31

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 1

Top Sponsors

Bayer 1 trials
Mayo Clinic 1 trials

Named interventions

Most-linked intervention names on Left Ventricular Systolic Dysfunction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo suspension Drug
1 trials
Vericiguat suspension Drug
1 trials
Vericiguat tablet Drug
1 trials
Finerenone (Kerendia, BAY94-8862) Drug
1 trials
Placebo tablet Drug
1 trials
Cardiac MRI Diagnostic test
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Left Ventricular Systolic Dysfunction trials. A trial with sites in several states counts in each.

Texas 2 trials
Pennsylvania 2 trials
Ohio 2 trials
New York 2 trials
Missouri 2 trials
Michigan 2 trials
Massachusetts 2 trials
Georgia 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Left Ventricular Systolic Dysfunction page

3 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 3 Left Ventricular Systolic Dysfunction trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Bayer sponsors the most Left Ventricular Systolic Dysfunction trials on record, review their full trial history before evaluating a specific study. See Bayer's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Left Ventricular Systolic Dysfunction condition card totals 3 registered trials; most-linked intervention Placebo suspension; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.